Silexion Therapeutics SLXN Income Statement (2023-2026)

NASDAQ SLXN
$0.16 +0.01 (+6.17%)
As of: Oct 21, 2026 · 3:14 PM EDT
Reported Financials

Silexion Therapeutics Quarterly Income Statement

Periods 13 quarters
Latest Jun 2026

Silexion Therapeutics reported revenue of -$0.01M and net income of -$3.55M for the quarter ended Jun 2026, up 67.4% year over year. This income statement covers 13 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue -0.04M-0.04M-0.03M-0.02M-0.01M0.02M0.01M-0.04M-0.04M-0.07M-0.03M-0.01M
Operating items
Research & DevelopmentR&D 1.24M0.54M1.26M0.96M0.77M3.22M0.87M0.59M1.02M2.16M3.38M1.37M2.21M
Selling, General & AdministrativeSG&A 0.18M0.20M0.47M0.29M0.62M4.82M1.03M1.06M1.27M1.14M1.03M1.38M1.47M
Other Operating ExpensesOther Opex 0.01M0.01M
Operating ExpensesOpex 1.41M0.73M1.73M1.25M1.39M8.04M1.90M1.65M2.28M3.29M4.41M2.75M3.68M
Operating IncomeOp. Inc -1.41M-0.73M-1.73M-1.25M-1.39M-8.04M-1.90M-1.65M-2.28M-3.29M-4.41M-2.75M-3.68M
EBIT -1.41M-0.73M-1.73M-1.25M-1.39M-8.04M-1.90M-1.65M-2.28M-3.29M-4.41M-2.75M-3.68M
Net income details
EBT -1.87M-0.80M-1.67M-1.42M-1.49M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Tax ProvisionsTaxes 0.01M0.01M0.01M0.01M0.00M0.00M0.00M0.00M
Profit After TaxPAT -1.88M-0.81M-1.68M-1.42M-1.49M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Income from Non-Controlling InterestsInc. Minority 0.22M0.02M-0.05M0.05M0.02M0.01M
Income from Continuing OperationsIncome (Continuing) -1.88M-0.81M-1.68M-1.42M-1.49M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Consolidated Net IncomeConsol Net Inc. -1.65M-0.81M-1.68M-1.42M-1.47M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Income towards Parent CompanyParent Net Inc -1.88M-0.81M-1.68M-1.42M-1.49M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Net Income towards Common StockholdersNet Income 1.65M-0.81M-1.68M-1.42M1.47M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Additional items
EPS (Basic) 0.01M0.00M0.00M0.00M0.01M0.00M-420.05-38.39-43.19-28.80-33.18-8.46-5.17
EPS (Diluted) 0.01M0.00M0.00M0.00M0.01M-0.01M-420.05-38.39-43.19-28.80-33.18-8.46-5.17
Shares Outstanding 187.00745.00745.00745.00186.000.00M0.00M0.05M0.06M0.11M0.13M0.32M0.69M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 187.00745.00745.00745.00186.000.00M0.00M0.05M0.06M0.11M0.13M0.32M0.69M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 187.00647.00647.00745.00186.000.00M0.00M0.05M0.06M0.11M0.13M0.31M0.69M
EBITDA -1.40M-0.72M-1.72M-1.24M-1.38M-8.01M-1.91M-1.65M-2.28M-3.29M-4.40M-2.75M-3.68M
Interest ExpensesInt Expense 0.03M0.01M

Silexion Therapeutics Income Statement API

Pull Silexion Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SLXN&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY